Applied Visual Sciences (OTCMKTS:APVS – Get Free Report) and BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) are both industrials companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, institutional ownership and risk.
Analyst Ratings
This is a summary of recent ratings and price targets for Applied Visual Sciences and BioNexus Gene Lab, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Applied Visual Sciences | 0 | 0 | 0 | 0 | 0.00 |
| BioNexus Gene Lab | 1 | 0 | 0 | 0 | 1.00 |
Given Applied Visual Sciences’ higher possible upside, equities analysts clearly believe Applied Visual Sciences is more favorable than BioNexus Gene Lab.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| Applied Visual Sciences | N/A | N/A | N/A |
| BioNexus Gene Lab | -82.38% | -32.92% | -29.75% |
Institutional & Insider Ownership
18.9% of BioNexus Gene Lab shares are owned by institutional investors. 33.0% of Applied Visual Sciences shares are owned by company insiders. Comparatively, 0.1% of BioNexus Gene Lab shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Applied Visual Sciences and BioNexus Gene Lab”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Applied Visual Sciences | N/A | N/A | N/A | N/A | N/A |
| BioNexus Gene Lab | $7.43 million | 0.59 | -$2.98 million | ($1.26) | -1.19 |
Applied Visual Sciences has higher earnings, but lower revenue than BioNexus Gene Lab.
Volatility & Risk
Applied Visual Sciences has a beta of 6.79, meaning that its share price is 579% more volatile than the S&P 500. Comparatively, BioNexus Gene Lab has a beta of 4.16, meaning that its share price is 316% more volatile than the S&P 500.
Summary
Applied Visual Sciences beats BioNexus Gene Lab on 6 of the 9 factors compared between the two stocks.
About Applied Visual Sciences
Applied Visual Sciences, Inc., a software technology company, designs and develops computer-vision detection solutions based on image processing science for aviation/homeland security and healthcare markets. It utilizes imaging technologies and analytics to create integrated information management technology products and services that address problems for corporations and governmental agencies. The company offers PinPoint, an intelligent computer-vision automated target recognition technology for the detection of guns, explosives, and other threat items contained in baggage in the airport environment or for building security applications; and Signature Mapping platform technology for use in the imaging field of diagnostic radiology and pathology. It also provides Signature Mapping Detection System, an automated hardware-software laboratory solution used to operate various infectious disease applications through multi-threaded detection algorithms. In addition, the company offers Signature Mapping Tuberculosis Detection software, an automated hardware and software technology platform; and Signature Mapping Breast Cancer Detection, a breast cancer detection solution. Applied Visual Sciences, Inc. markets its products through direct sales and indirect distribution channels worldwide. The company was formerly known as Guardian Technologies International, Inc. and changed its name to Applied Visual Sciences, Inc. in July 2010. Applied Visual Sciences, Inc. was founded in 1989 and is based in Leesburg, Virginia.
About BioNexus Gene Lab
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Receive News & Ratings for Applied Visual Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Visual Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
